NYSEAMERICAN:SENS - Senseonics Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $2.17
  • Forecasted Upside: -41.28 %
  • Number of Analysts: 5
  • Breakdown:
  • 2 Sell Ratings
  • 2 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$3.69
▼ -0.27 (-6.82%)
1 month | 3 months | 12 months
Get New Senseonics Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SENS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SENS

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$2.17
▼ -41.28% Downside Potential
This price target is based on 5 analysts offering 12 month price targets for Senseonics in the last 3 months. The average price target is $2.17, with a high forecast of $3.00 and a low forecast of $1.00. The average price target represents a -41.28% upside from the last price of $3.69.

Hold

The current consensus among 5 polled investment analysts is to hold stock in Senseonics. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 2 sell ratings
12/23/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 2 sell ratings
3/22/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 3 sell ratings
6/20/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 3 sell ratings
9/18/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 3 sell ratings
12/17/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 3 sell ratings
3/17/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 3 sell ratings
5/16/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 2 sell ratings
6/15/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 2 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
4/1/2021SVB LeerinkDowngradeOutperform ➝ Market Perform$3.00
i
Rating by D. Antalffy at SVB Leerink LLC
3/11/2021Raymond JamesReiterated RatingMarket Perform ➝ Underperform
i
3/5/2021Stifel NicolausBoost Price TargetBuy$1.00 ➝ $2.50
i
3/5/2021SVB LeerinkBoost Price TargetOutperform$1.00 ➝ $3.00
i
3/5/2021Raymond JamesDowngradeMarket Perform ➝ Underperform
i
1/26/2021Stifel NicolausReiterated RatingBuy$1.85
i
1/20/2021BTIG ResearchDowngradeBuy ➝ Neutral
i
Rating by Marie Thibault at BTIG Research
1/20/2021Craig HallumDowngradeHold ➝ Sell
i
12/23/2020BTIG ResearchReiterated RatingBuy$1.00
i
Rating by Marie Thibault at BTIG Research
8/16/2020Raymond JamesReiterated RatingHold
i
8/11/2020Craig HallumUpgradeSell ➝ Hold
i
Rating by Alexander Nowak at Craig Hallum
8/10/2020BTIG ResearchUpgradeNeutral ➝ Buy$1.00
i
Rating by Marie Thibault at BTIG Research
6/10/2020BTIG ResearchReiterated RatingHold
i
Rating by Marie Thibault at BTIG Research
6/10/2020Stifel NicolausLower Price TargetBuy$1.85 ➝ $1.00
i
6/10/2020SVB LeerinkLower Price TargetOutperform$2.00 ➝ $1.00
i
5/21/2020UBS GroupLower Price TargetSell$0.70 ➝ $0.25
i
4/22/2020BTIG ResearchReiterated RatingHold ➝ Neutral
i
Rating by Marie Thibault at BTIG Research
3/27/2020Craig HallumDowngradeSell$0.40
i
Rating by Alexander Nowak at Craig Hallum
3/13/2020Canaccord GenuityLower Price TargetHold$1.00 ➝ $0.75
i
3/13/2020BTIG ResearchDowngradeBuy ➝ Neutral
i
3/13/2020GuggenheimDowngradeBuy ➝ Neutral
i
11/13/2019Craig HallumDowngradeBuy ➝ Hold$2.50
i
11/13/2019Canaccord GenuityDowngradeBuy ➝ Hold$2.00 ➝ $1.00
i
10/22/2019Stifel NicolausInitiated CoverageBuy$2.00
i
9/4/2019Piper Jaffray CompaniesSet Price TargetHold$2.00
i
Rating by JP McKim at Piper Jaffray Companies
8/11/2019BTIG ResearchReiterated RatingBuy$2.00
i
7/24/2019BTIG ResearchReiterated RatingBuy$2.00
i
7/5/2019Raymond JamesDowngradeOutperform ➝ Market Perform
i
1/29/2019Piper Jaffray CompaniesInitiated CoverageNeutral
i
11/27/2018UBS GroupInitiated CoverageSell
i
8/27/2018Dougherty & CoReiterated RatingBuy$6.00
i
Rating by K. Bauser at Dougherty & Co
8/24/2018Dougherty & CoInitiated CoverageBuy ➝ Buy$6.00
i
Rating by K. Bauser at Dougherty & Co
8/9/2018BTIG ResearchReiterated RatingBuy$6.00
i
6/22/2018Raymond JamesBoost Price TargetOutperform ➝ Outperform$4.00 ➝ $6.00
i
6/11/2018Craig HallumInitiated CoverageBuy$7.00
i
6/7/2018BTIG ResearchReiterated RatingBuy$5.00
i
5/18/2018Canaccord GenuityReiterated RatingBuy$5.00
i
5/13/2018BTIG ResearchReiterated RatingBuy$5.00
i
4/3/2018GuggenheimInitiated CoverageBuy$6.00
i
3/2/2018Canaccord GenuityReiterated RatingBuy
i
11/1/2017Canaccord GenuityReiterated RatingBuy
i
9/28/2017Canaccord GenuityReiterated RatingBuy
i
5/28/2017BTIG ResearchReiterated RatingBuy$4.50
i
5/10/2017B. RileyReiterated RatingBuy$4.00
i
5/5/2017B. RileyReiterated RatingBuy$4.00
i
3/1/2017B. RileyReiterated RatingBuy$5.00
i
2/27/2017Canaccord GenuityReiterated RatingBuy$5.00
i
Rating by Kyle Rose at Canaccord Genuity
2/24/2017B. RileyReiterated RatingBuy$5.00
i
2/17/2017Canaccord GenuityReiterated RatingBuy$6.00
i
Rating by Kyle Rose at Canaccord Genuity
2/6/2017Canaccord GenuityReiterated RatingBuy$6.00
i
Rating by Kyle Rose at Canaccord Genuity
2/1/2017B. RileyReiterated RatingBuy$5.00
i
1/27/2017B. RileyReiterated RatingBuy$5.00
i
1/23/2017Canaccord GenuitySet Price TargetBuy$6.00
i
Rating by Kyle Rose at Canaccord Genuity
9/27/2016B. RileyReiterated RatingBuy
i
Rating by G. Chodaczek at B. Riley
(Data available from 6/16/2016 forward)
Senseonics logo
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to 90 and 180 days. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company was founded in 1996 and is headquartered in Germantown, Maryland.
Read More

Today's Range

Now: $3.69
$3.50
$3.89

50 Day Range

MA: $0.48
$0.36
$0.95

52 Week Range

Now: $3.69
$0.35
$5.56

Volume

57,745,233 shs

Average Volume

44,004,887 shs

Market Capitalization

$1.58 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.41

Frequently Asked Questions

What sell-side analysts currently cover shares of Senseonics?

The following equities research analysts have issued stock ratings on Senseonics in the last twelve months: BTIG Research, Craig Hallum, Raymond James, Stifel Nicolaus, SVB Leerink LLC, and Zacks Investment Research.
View the latest analyst ratings for SENS.

What is the current price target for Senseonics?

3 Wall Street analysts have set twelve-month price targets for Senseonics in the last year. Their average twelve-month price target is $2.17, suggesting a possible downside of 41.3%. SVB Leerink LLC has the highest price target set, predicting SENS will reach $3.00 in the next twelve months. BTIG Research has the lowest price target set, forecasting a price of $1.00 for Senseonics in the next year.
View the latest price targets for SENS.

What is the current consensus analyst rating for Senseonics?

Senseonics currently has 2 sell ratings, 2 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in SENS, but not buy more shares or sell existing shares.
View the latest ratings for SENS.

What other companies compete with Senseonics?

How do I contact Senseonics' investor relations team?

Senseonics' physical mailing address is 20451 Seneca Meadows Pkwy, GERMANTOWN, MD 20876-7005, United States. The company's listed phone number is (301) 515-7260. The official website for Senseonics is www.senseonics.com.